Skip to main content
Top
Published in: Breast Cancer 3/2011

01-07-2011 | Special Feature

Mammography and ultrasound features of triple-negative breast cancer

Authors: Yasuyuki Kojima, Hiroko Tsunoda

Published in: Breast Cancer | Issue 3/2011

Login to get access

Abstract

Background

Triple-negative breast cancer is characterized as a cancer with a high malignancy potential and a poor prognosis. Therefore, early detection of this subtype of breast cancer is vital. In this paper, we describe the mammography and ultrasound findings of triple-negative breast cancer in a large population and investigate the specific features of this subtype.

Methods

From January 2007 to April 2010, mammography and ultrasound findings of 88 patients with triple-negative breast cancer were retrospectively reviewed. In this cohort, 52 patients underwent neoadjuvant chemotherapy. We compared the pathological chemotherapy effects and radiological findings among these patients. Mammograms were reviewed according to the Japanese mammography guideline. Ultrasound findings were classified as masses, low echoic area, distortions, and calcifications. Noted features included shapes, patterns of internal echoes, posterior echoes, vascularity, and elasticity scores.

Results

On mammography, triple-negative breast cancers frequently presented with a mass (62.4%). Masses with microlobulated margins were the most frequent (39.6%), indistinct (32.0%) and circumscribed (20.8%) were commonly observed, but spiculated margins were rare (4.7%). On ultrasound, cancers were more likely to present as a mass (92.5%), and less likely to show attenuating posterior echoes (8.8%). Of the 40 cases obtained via elasticity imaging, 35 (87.5%) lesions were scored as 4 or 5. There were no significant differences in the mammography or ultrasound findings between the chemotherapy effects.

Conclusion

Mammography and ultrasound imaging together revealed that the morphological features of triple-negative breast cancer include a lobulated mass, with less attenuating posterior echoes, some vascularity, and low elasticity.
Literature
1.
go back to reference Cleator S, Heller W, Coombes RC. Triple-negative breast cancer: therapeutic options. Lancet Oncol. 2007;8:235–44.PubMedCrossRef Cleator S, Heller W, Coombes RC. Triple-negative breast cancer: therapeutic options. Lancet Oncol. 2007;8:235–44.PubMedCrossRef
2.
go back to reference Reis-Filho JS, Tutt AN. Triple negative tumours: a critical review. Histopathology. 2008;52:108–18.PubMedCrossRef Reis-Filho JS, Tutt AN. Triple negative tumours: a critical review. Histopathology. 2008;52:108–18.PubMedCrossRef
3.
go back to reference Shiu KK, Tan DS, Reis-Filho JS. Development of therapeutic approaches to ‘triple negative’ phenotype breast cancer. Expert Opin Ther Targets. 2008;2:1123–37.CrossRef Shiu KK, Tan DS, Reis-Filho JS. Development of therapeutic approaches to ‘triple negative’ phenotype breast cancer. Expert Opin Ther Targets. 2008;2:1123–37.CrossRef
4.
go back to reference The Committee of Mammography Guideline (Japan Radiological Society, Japanese Society of Radiological Technology). Mammography guideline. 2nd ed. Tokyo: Igaku Syoin; 2004 (in Japanese). The Committee of Mammography Guideline (Japan Radiological Society, Japanese Society of Radiological Technology). Mammography guideline. 2nd ed. Tokyo: Igaku Syoin; 2004 (in Japanese).
5.
go back to reference Itoh A, Ueno E, Tohno E, Kamma H, Takahashi H, Shiina T, et al. Breast disease: clinical application of US elastography for diagnosis. Radiology. 2006;239:341–50.PubMedCrossRef Itoh A, Ueno E, Tohno E, Kamma H, Takahashi H, Shiina T, et al. Breast disease: clinical application of US elastography for diagnosis. Radiology. 2006;239:341–50.PubMedCrossRef
6.
go back to reference Ko ES, Lee BH, Kim HA, Noh WC, Kim MS, Lee SA. Triple-negative breast cancer: correlation between imaging and pathological findings. Eur Radiol. 2010;20:1111–7.PubMedCrossRef Ko ES, Lee BH, Kim HA, Noh WC, Kim MS, Lee SA. Triple-negative breast cancer: correlation between imaging and pathological findings. Eur Radiol. 2010;20:1111–7.PubMedCrossRef
7.
go back to reference Wang Y, Ikeda DM, Narasimhan B, Longacre TA, Bleicher RJ, Pal S, et al. Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression. Radiology. 2008;246:367–75.PubMedCrossRef Wang Y, Ikeda DM, Narasimhan B, Longacre TA, Bleicher RJ, Pal S, et al. Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression. Radiology. 2008;246:367–75.PubMedCrossRef
8.
go back to reference Yang WT, Dryden M, Broglio K, Gilcrease M, Dawood S, Dempsey PJ, et al. Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women. Breast Cancer Res Treat. 2008;111:405–10.PubMedCrossRef Yang WT, Dryden M, Broglio K, Gilcrease M, Dawood S, Dempsey PJ, et al. Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women. Breast Cancer Res Treat. 2008;111:405–10.PubMedCrossRef
9.
go back to reference Barry WT, Kernagis DN, Dressman HK, Griffis RJ, Hunter JD, Olson JA, et al. Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcome. J Clin Oncol. 2010;28:2198–206.PubMedCrossRef Barry WT, Kernagis DN, Dressman HK, Griffis RJ, Hunter JD, Olson JA, et al. Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcome. J Clin Oncol. 2010;28:2198–206.PubMedCrossRef
10.
go back to reference Mann GB, Fahey VD, Feleppa F, Buchanan MR. Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer. J Clin Oncol. 2005;23:5148–54.PubMedCrossRef Mann GB, Fahey VD, Feleppa F, Buchanan MR. Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer. J Clin Oncol. 2005;23:5148–54.PubMedCrossRef
11.
go back to reference Horii R, Akiyama F, Ito Y, Matsuura M, Miki Y, Iwase T. Histological features of breast cancer, highly sensitive to chemotherapy. Breast Cancer. 2007;14:393–400.PubMedCrossRef Horii R, Akiyama F, Ito Y, Matsuura M, Miki Y, Iwase T. Histological features of breast cancer, highly sensitive to chemotherapy. Breast Cancer. 2007;14:393–400.PubMedCrossRef
12.
go back to reference Tsunoda-Shimizu H, Hayashi N, Hamaoka T, Kawasaki T, Tsugawa K, Yagata H, et al. Determining the morphological features of breast cancer and predicting the effects of neoadjuvant chemotherapy via diagnostic breast imaging. Breast Cancer. 2008;15:133–40.PubMedCrossRef Tsunoda-Shimizu H, Hayashi N, Hamaoka T, Kawasaki T, Tsugawa K, Yagata H, et al. Determining the morphological features of breast cancer and predicting the effects of neoadjuvant chemotherapy via diagnostic breast imaging. Breast Cancer. 2008;15:133–40.PubMedCrossRef
Metadata
Title
Mammography and ultrasound features of triple-negative breast cancer
Authors
Yasuyuki Kojima
Hiroko Tsunoda
Publication date
01-07-2011
Publisher
Springer Japan
Published in
Breast Cancer / Issue 3/2011
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-010-0223-8

Other articles of this Issue 3/2011

Breast Cancer 3/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine